3 months ago
PODD
AnalystsLee HambrightLee Hambright's Stock Forecasts
AnalystsLee Hambright
Analyst Ranking
Bottom 14%
#4819 out of 5550 analysts
Average Return
-0.91%
Win Rate
52%17 out of 33
Risk vs Reward
Poor
Good
Lee Hambright's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dexcom IncDXCM | +73.52% | $79.14 | $137.32 | 2022-07-15 - 2023-07-14 | Buy |
Insulet CorpPODD | +31.40% | $239.30 | $314.44 | 2024-11-06 - 2025-11-05 | Buy |
Intuitive Surgical IncISRG | +31.04% | $307.84 | $403.39 | 2023-05-31 - 2024-05-30 | Buy |
Intuitive Surgical IncISRG | +25.07% | $345.42 | $432.01 | 2026-07-17 - 2026-10-30 | Buy |
Edwards Lifesciences CorpEW | +24.63% | $21.67 | $27.00 | 2014-12-04 - 2015-12-04 | Buy |
Lee Hambright Analyst Color
Get additional color on Lee Hambright's coverage of popular stocks
3 months ago
ISRG
Lee Hambright's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zimmer Biomet Holdings IncZBH | 3 | Hold | $93.00 | -1.61% | Maintains | 3 months ago |
Insulet CorpPODD | 5 | Buy | $175.00 | +16.92% | Maintains | 3 months ago |
Intuitive Surgical IncISRG | 5 | Buy | $685.00 | +58.56% | Maintains | 3 months ago |
Medtronic PLCMDT | 5 | Buy | $97.00 | +0.48% | Maintains | 5 months ago |
Medline IncMDLN | 2 | Buy | $54.00 | +68.12% | Maintains | 6 months ago |
Abbott LaboratoriesABT | 7 | Buy | $125.00 | +17.70% | Maintains | 9 months ago |
Tandem Diabetes Care IncTNDM | 2 | Hold | $25.00 | +30.82% | Maintains | 10 months ago |
Stryker CorpSYK | 2 | Buy | $465.00 | +59.32% | Maintains | 10 months ago |
Johnson & JohnsonJNJ | 3 | Hold | $208.00 | -23.87% | Maintains | 10 months ago |
Dexcom IncDXCM | 3 | Buy | $86.00 | +4.51% | Maintains | 10 months ago |
Boston Scientific CorpBSX | 1 | Buy | $100.00 | N/A | Maintains | 2 years ago |
Edwards Lifesciences CorpEW | 3 | Buy | $135.00 | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.